CRIS Current Research Information System

GARAJOVA, INGRID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.327
EU - Europa 1.664
AS - Asia 787
AF - Africa 90
SA - Sud America 10
OC - Oceania 6
Totale 4.884
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.309
GB - Regno Unito 451
IT - Italia 332
CN - Cina 267
SG - Singapore 230
SE - Svezia 227
DE - Germania 195
VN - Vietnam 156
IN - India 86
IE - Irlanda 74
CH - Svizzera 71
RU - Federazione Russa 68
FR - Francia 60
FI - Finlandia 37
ZA - Sudafrica 36
EE - Estonia 34
UA - Ucraina 34
TG - Togo 33
BG - Bulgaria 18
BE - Belgio 15
JO - Giordania 15
CA - Canada 14
GR - Grecia 11
NL - Olanda 10
CI - Costa d'Avorio 9
ID - Indonesia 7
NG - Nigeria 7
TR - Turchia 6
AU - Australia 5
BR - Brasile 5
IR - Iran 5
NI - Nicaragua 4
PT - Portogallo 4
CL - Cile 3
ES - Italia 3
HR - Croazia 3
KR - Corea 3
PL - Polonia 3
RO - Romania 3
AT - Austria 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HK - Hong Kong 2
LB - Libano 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AR - Argentina 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
JP - Giappone 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.884
Salva come PNG Salva come JPEG
Città #
Southend 410
Fairfield 283
Chandler 223
Singapore 196
Ashburn 151
Santa Clara 147
Wilmington 137
Houston 131
Woodbridge 125
Seattle 120
Ann Arbor 118
Dong Ket 98
Princeton 97
Cambridge 96
Dublin 74
Bern 66
Boardman 66
Bologna 65
Nanjing 46
Westminster 42
Helsinki 37
Padova 37
Berlin 35
Lomé 33
Medford 21
New York 21
Beijing 20
Saint Petersburg 19
Sofia 18
Milan 16
Shenyang 16
Turin 16
Amman 15
Brussels 14
Changsha 14
San Diego 14
Hebei 12
Jinan 12
Rome 12
Dearborn 11
Ravenna 11
Toronto 10
Abidjan 9
Guangzhou 9
Jacksonville 9
Falls Church 8
Frankfurt am Main 8
Olalla 8
Tianjin 8
Zhengzhou 8
Abeokuta 7
Mülheim 7
Torino 7
Florence 6
Nanchang 6
Norwalk 6
Redwood City 6
Ardabil 5
Bühl 5
Hangzhou 5
Hefei 5
Jakarta 5
Jiaxing 5
Kunming 5
London 5
Pune 5
Redmond 5
Shanghai 5
Amsterdam 4
Bremen 4
Istanbul 4
Managua 4
Melbourne 4
Orange 4
Paris 4
Parma 4
Phoenix 4
Wuhan 4
Athens 3
Cesena 3
Columbus 3
Den Haag 3
Kuban 3
Lausanne 3
Los Angeles 3
Ningbo 3
Nuremberg 3
Prineville 3
Rimini 3
São Paulo 3
Arzignano 2
Baoding 2
Bari 2
Bratislava 2
Chicago 2
Chongqing 2
Cinisello Balsamo 2
Dhaka 2
Empoli 2
Forlì 2
Totale 3.368
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 276
219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy 175
D32Left versus right side primary tumor: the correlation with clinical outcome of patients with resected stage II and III colorectal cancer 171
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 171
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 150
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma 147
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 146
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 144
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept 135
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 135
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications 133
In Reply 124
Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX combination therapy in advanced pancreatic ductal adenocarcinoma 118
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 116
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 116
Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac) 115
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer 114
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA 112
Antiapoptotic genes are overexpressed in the group of patients with locally advanced rectal adenocarcinomas who do not respond to neoadjuvant chemoradiotherapy 112
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 112
c-Met as a Target for Personalized Therapy 109
Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation. 107
380 POSTER Association of miR21, miR31, miR143, miR145 and let-7a-1 levels with histopathologic features of colorectal cancer 106
Altered expression of heat shock protein 110 (HSP110), hypoxia up- regulated 1 (HYOU1) and translationally controled tumor protein (TCTP) during colorectal cancer progression 103
Second-line chemotherapy in biliary tract cancer patients. 96
Prognostic significance of tumor-infiltrating cytotoxic T-cells in colorectal cancer 96
Oxaliplatin in pre-treated patients: Maybe not the match point? 95
Neoadjuvant treatment in rectal cancer: actual status. 94
D43Capecitabine and Regorafenib-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer 94
Second-line chemotherapy in patients with biliary tract cancer. 93
The follow-up issues: from the necessity to the opportunity 90
The role of microRNAs in resistance to current pancreatic cancer treatment: Translational studies and basic protocols for extraction and PCR analysis 90
Significant overexpression of Hsp110 gene during colorectal cancer progression 90
Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients. 85
L27MiR-21 expression as prognostic biomarker in extrahepatic but not intrahepatic radically resected cholangiocarcinomas 85
D44The overall survival of patients affected by metastatic colorectal cancer before and after “monoclonal antibodies era”: a monocentric retrospective study 83
[Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma] 82
Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer 82
MicroRNA profiling of primary pulmonary enteric adenocarcinoma shows similarity with lung cancer and pancreatic cancer 81
[Gene expression profiling in prediction of tumor response to neoadjuvant concomitant chemoradiotherapy in patients with locally advanced rectal carcinoma: pilot study] 78
Occupational exposure to asbestos: a putative unknown risk factor for intrahepatic cholangiocarcinoma. 75
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 63
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 39
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 38
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development 38
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials 33
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis 24
Synchronous and metachronous colorectal liver metastases: Impact of primary tumor location on patterns of recurrence and survival after hepatic resection 17
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 16
Should patients on levothyroxine therapy be screened for pancreatic cancer? 15
Totale 5.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020594 0 0 0 0 0 0 137 148 137 74 47 51
2020/2021579 115 36 18 17 6 32 26 33 58 32 21 185
2021/2022808 83 36 35 46 84 46 25 50 45 32 163 163
2022/20231.037 114 169 76 101 68 66 24 83 140 38 66 92
2023/2024269 39 40 9 32 11 51 9 17 11 14 22 14
2024/2025751 54 215 118 73 215 55 21 0 0 0 0 0
Totale 5.019